IN2014MN02228A - - Google Patents
Info
- Publication number
- IN2014MN02228A IN2014MN02228A IN2228MUN2014A IN2014MN02228A IN 2014MN02228 A IN2014MN02228 A IN 2014MN02228A IN 2228MUN2014 A IN2228MUN2014 A IN 2228MUN2014A IN 2014MN02228 A IN2014MN02228 A IN 2014MN02228A
- Authority
- IN
- India
- Prior art keywords
- jak2
- inden
- imidazo
- pyrazol
- pyridin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The present invention provides an amino pyrazole compound which is 3 [(lR) 6 fluoro 2 3 dihydro 1H inden l yl] N (3 methyl IH pyrazol 5 yl) 3H imidazo[4 5 b]pyridin 5 amine or a pharmaceutically acceptable salt thereof that inhibits JAK1 and JAK2 and therefore may be useful in treating cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261659679P | 2012-06-14 | 2012-06-14 | |
PCT/US2013/044211 WO2013188184A1 (en) | 2012-06-14 | 2013-06-05 | Inhibitor of jak1 and jak2 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02228A true IN2014MN02228A (en) | 2015-07-17 |
Family
ID=48626679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2228MUN2014 IN2014MN02228A (en) | 2012-06-14 | 2013-06-05 |
Country Status (14)
Country | Link |
---|---|
US (1) | US9062050B2 (en) |
EP (1) | EP2861231B1 (en) |
JP (1) | JP6092376B2 (en) |
KR (1) | KR20150008907A (en) |
CN (1) | CN104349775B (en) |
AU (1) | AU2013274641B2 (en) |
BR (1) | BR112014030651A2 (en) |
CA (1) | CA2871659C (en) |
EA (1) | EA201492104A1 (en) |
ES (1) | ES2605827T3 (en) |
IN (1) | IN2014MN02228A (en) |
MX (1) | MX2014015271A (en) |
WO (1) | WO2013188184A1 (en) |
ZA (1) | ZA201407940B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR105400A1 (en) * | 2015-08-04 | 2017-09-27 | Lilly Co Eli | JAK1 INHIBITORS |
CN114364798A (en) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | Combination of Dbait molecules with kinase inhibitors for the treatment of cancer |
CN110229067A (en) * | 2019-06-05 | 2019-09-13 | 南京焕然生物科技有限公司 | A kind of 2- amino indenes preparation method |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
CN115141195B (en) * | 2021-03-03 | 2024-02-06 | 成都先导药物开发股份有限公司 | NUAK inhibitor and application thereof |
US20230146125A1 (en) * | 2021-11-09 | 2023-05-11 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1853588T1 (en) | 2005-02-16 | 2008-10-31 | Astrazeneca Ab | Chemical compounds |
JO3235B1 (en) * | 2006-05-26 | 2018-03-08 | Astex Therapeutics Ltd | Pyrrolopyrimidine compounds and their uses |
WO2008129255A1 (en) * | 2007-04-18 | 2008-10-30 | Astrazeneca Ab | 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer |
-
2013
- 2013-06-05 EA EA201492104A patent/EA201492104A1/en unknown
- 2013-06-05 CN CN201380031385.1A patent/CN104349775B/en not_active Expired - Fee Related
- 2013-06-05 AU AU2013274641A patent/AU2013274641B2/en not_active Ceased
- 2013-06-05 CA CA2871659A patent/CA2871659C/en not_active Expired - Fee Related
- 2013-06-05 ES ES13729215.7T patent/ES2605827T3/en active Active
- 2013-06-05 KR KR20147034683A patent/KR20150008907A/en active IP Right Grant
- 2013-06-05 JP JP2015517311A patent/JP6092376B2/en not_active Expired - Fee Related
- 2013-06-05 IN IN2228MUN2014 patent/IN2014MN02228A/en unknown
- 2013-06-05 WO PCT/US2013/044211 patent/WO2013188184A1/en active Application Filing
- 2013-06-05 BR BR112014030651A patent/BR112014030651A2/en not_active IP Right Cessation
- 2013-06-05 EP EP13729215.7A patent/EP2861231B1/en not_active Not-in-force
- 2013-06-05 MX MX2014015271A patent/MX2014015271A/en unknown
- 2013-06-05 US US14/402,146 patent/US9062050B2/en not_active Expired - Fee Related
-
2014
- 2014-10-30 ZA ZA2014/07940A patent/ZA201407940B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2014015271A (en) | 2015-03-05 |
US9062050B2 (en) | 2015-06-23 |
CN104349775A (en) | 2015-02-11 |
WO2013188184A1 (en) | 2013-12-19 |
JP2015519396A (en) | 2015-07-09 |
ZA201407940B (en) | 2016-05-25 |
EP2861231A1 (en) | 2015-04-22 |
US20150133490A1 (en) | 2015-05-14 |
CA2871659C (en) | 2017-04-04 |
CN104349775B (en) | 2017-06-06 |
BR112014030651A2 (en) | 2017-06-27 |
ES2605827T3 (en) | 2017-03-16 |
EP2861231B1 (en) | 2016-08-31 |
JP6092376B2 (en) | 2017-03-08 |
AU2013274641B2 (en) | 2015-09-24 |
CA2871659A1 (en) | 2013-12-19 |
EA201492104A1 (en) | 2015-06-30 |
AU2013274641A1 (en) | 2014-11-20 |
KR20150008907A (en) | 2015-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02228A (en) | ||
PH12014501986A1 (en) | 2-amino, 6-phenyl substituted pyrido [2,3-d] pyrimidine derivatives useful as raf kinase inhibitors | |
IL266170A (en) | Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof | |
MX370814B (en) | Substituted pyrazolo[3,4-d]pyrimidines and uses thereof. | |
NZ744349A (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
SG11201907095UA (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
LT3418281T (en) | Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases | |
IL266305B (en) | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors | |
JO3819B1 (en) | 1H-Pyrazolo[4,3-b]pyridines as PDE1 inhibitors | |
MX2018003861A (en) | New pyrrolo[2,3-d]pyrimidine derivatives as dual dyrk1/clk1 inhibitors. | |
PH12019501022A1 (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
IL247948B (en) | Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1h-imidazo[1,2-b]pyrazole derivatives as ros1 inhibitors | |
IL268923A (en) | Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives | |
IL280513A (en) | Imidazo[1,2-b]pyridazines as trk inhibitors | |
IL266986B (en) | Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors | |
IL272988A (en) | Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors | |
IL280122A (en) | Imidazo[1,2-b]pyridazine derivatives as trk inhibitors | |
PT3621966T (en) | Pyrazole[1,5-a]pyrimidine derivatives as kinase jak inhibitors | |
LV14663A (en) | Synthesis of pyrrolo[1,2-a]quinazoline derivatives from anthranilic acid hydrazides and alfa-ketoacids |